Companies
Bristol Myers Squibb
PharmaceuticalsPrinceton, New JerseyBMYAbout 32,500 employees
WorkHush has 3 source-backed updates on Bristol Myers Squibb workforce changes since February 2026. The latest, added September 22, 2026: 265 jobs in September 2026 New Jersey WARN notice (Princeton) (WARN notice). Layoffs are under way until December 31, 2026. Read it with sources ›
More about Bristol Myers Squibb
Drugmaker that develops and sells prescription medicines for cancer, blood disorders, immune diseases, heart disease and mental illness
Revenue
$48.2B
Fiscal 2025, roughly flat
Employees
About 32,500
As of December 2025
Stock
BMY
New York Stock Exchange
Headquarters
Princeton, New Jersey
CEO
Christopher Boerner
Since 2023
BrandsOpdivo, Eliquis, Revlimid, Cobenfy, Camzyos, Breyanzi
Current strategyCutting about $2B in costs by 2027 to offset patent expirations while building newer drugs
Recent workforce changes718 New Jersey jobs cut in 2026, in rounds announced in February, April and September (265)
CompetitorsMerck, Pfizer, AbbVie
Checked October 11, 2026 · Sources: sec.gov, thesunpapers.com
Bristol Myers Squibb · WARN notice265 jobs in September 2026 New Jersey WARN notice (Princeton)New Jersey WARN notice posted September 2026; effective December 17, 2026 to May 21, 2027 · Sources: New Jersey Department of Labor WARN report, Fierce Pharma, NJBIZBristol Myers Squibb · WARN notice206 jobs in April 2026 New Jersey WARN notice (Lawrence Township)New Jersey WARN notice posted April 2026; effective July 16 to December 31, 2026 · Sources: New Jersey Department of Labor WARN report, NJBIZBristol Myers Squibb · Company reportHeadcount fell to about 32,500 from about 34,100Annual report filed February 11, 2026 (year ended December 31, 2025) · Sources: SEC Form 10-K (FY2025), SEC Form 10-K (FY2024), SEC Form 8-K (BMS earnings release)
No one has posted about Bristol Myers Squibb yet. Be the first to post ›
Follow Bristol Myers Squibb in a feed reader, no account needed: RSS feed